Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Alliance News UK - Start Of Day

Thu, 24th Sep 2020 06:00

(Alliance News) - Welcome to the Alliance News UK service (ISSN 2515-9453), consisting of the Alliance News UK Professional and its family of financial newswires serving investors and their professional advisers.

Alliance News UK is published by Alliance News Limited, whose registered office is at 16 Carver Road, London SE24 9LT, UK.

To speak to our editorial team, email us at newsroom@alliancenews.com

For information about subscribing to Alliance News UK, email us at info@alliancenews.com or visit our website at www.alliancenews.com

Alliance News UK provides independent news coverage of every company listed on the London Stock Exchange, including closed-end investment trusts, together with relevant political and economic news from around the world.

Terms Of Use and Disclaimer

Alliance News UK (the "Content") is the property of Alliance News Ltd or its licensors, and is protected by copyright and other intellectual property laws. The Content may be used only for your personal and non-commercial use. You agree not to copy, reproduce, modify, display, perform, publish, create derivative works from, or store any of the Content. You also agree not to distribute, communicate, transmit, broadcast or circulate any of the Content to anyone, including but not limited to someone else in the same company or organisation, without the express prior written consent of Alliance News, with this one exception:

You may, on an occasional and irregular basis, reproduce, distribute, display, communicate or transmit an insubstantial portion of the Content, for a non-commercial purpose and without charge, to a limited number of individuals, provided you include all copyright and other proprietary rights notices with such portion of the Content in the same form in which the notices appear within the Content, the original source attribution, and the phrase "Used with permission from Alliance News".

However, you may not post any of the Content to forums, newsgroups, mail lists, electronic bulletin boards, or other websites, without the prior written consent of Alliance News.

To request consent for other matters, you may contact Alliance News on info@alliancenews.com.

We do not guarantee that the Content will always be available or uninterrupted nor that this website will be free from bugs or viruses. We may suspend, withdraw, discontinue or change any part of the Content without notice.

The Content includes facts, views, opinions and recommendations of individuals and organisations deemed of interest. Alliance News and its Content licensors are not giving investment advice, tax advice, legal advice, or other professional advice on which it is intended that you should rely. Alliance News and its Content licensors do not guarantee or warrant the accuracy, completeness or timeliness of, or otherwise endorse, these views, opinions and recommendations. You should always seek the assistance of a professional for advice on investments, tax, the law, or other professional matters.

Alliance News has no liability to you whatsoever for any loss or damage in connection with, or inability to use, this website or use of, or reliance on, the Content.

We may revise these Terms of Use at any time. Please check from time to time as these Terms of Use, and any changes made to them, are binding on you.

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

UPDATE 1-AstraZeneca weighs seeking full U.S. approval for COVID shot - WSJ

(Adds background related to AstraZeneca vaccine)May 7 (Reuters) - AstraZeneca Plc may skip asking the U.S. Food and Drug Administration for emergency-use authorization for its COVID-19 vaccine and instead pursue the more time-intensive application...

7 May 21 23:23

AstraZeneca weighs seeking full U.S. approval for COVID-19 shot -WSJ

May 7 (Reuters) - AstraZeneca Plc may skip asking the U.S. Food and Drug Administration for emergency-use authorization for its COVID-19 vaccine, and instead pursue the more time-intensive application for a full-fledged license to sell the shot, ...

7 May 21 22:52

UPDATE: Portugal in handful of countries on England green travel list

UPDATE: Portugal in handful of countries on England green travel list

7 May 21 21:22

UPDATE: SNP majority still uncertain, despite Sturgeon's party gaining

UPDATE: SNP majority still uncertain, despite Sturgeon's party gaining

7 May 21 21:19

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.